The Canada Pension Plan Investment Board (CPPIB), one of the world’s largest pension funds, has agreed to invest $100 million in Hong Kong-based Hutchison China MediTech (Chi-Med), a Nasdaq-listed biopharmaceutical company.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
